IP Library › Assignment 070200/0296
Patent Assignment
Reel/Frame 070200/0296

Assignment of Assignor's Interest

Recorded: 2025-02-12 Pages: 7
Assignors
CHRISTENSEN, DALE
Executed: 2020-05-01
KOLENG, JOHN J.
Executed: 2019-09-10
Assignee
LUNG THERAPEUTICS, INC.
2801 VIA FORTUNA, SUITE 425, AUSTIN, TEXAS, 78746
Covered Property (1)
Dry Powder Formulation of Caveolin-1 Peptides and Methods of Use Thereof
Application: 18/434,731 →
Publication: US 2024/0269225
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger and Change of Name Apr 9, 2024
From: LUNG THERAPEUTICS, INC.; AT MERGER SUB II, LLC
To: LUNG THERAPEUTICS, LLC
Reel/Frame 067043/0478 →
Assignment of Assignor's Interest Dec 5, 2024
From: SHETTY, SREERAMA
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 069498/0648 →
Assignment of Assignor's Interest Feb 12, 2025
From: WILLIAMS, ROBERT O., III; WATTS, ALAN B.; ZHANG, YAJIE; SAHAKIJPIJARN, SAWITTREE
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 070200/0363 →
Assignment of Assignor's Interest Mar 3, 2025
From: LUNG THERAPEUTICS, LLC
To: REIN THERAPEUTICS, INC.
Reel/Frame 070380/0626 →